Al-ruwag

Al-ruwag (Ocimum gratissimum) contains eugenol (up to 76% of essential oil), thymol, rosmarinic acid, and flavonoids such as luteolin and vicenin-2, which exert antioxidant, antimicrobial, and anti-inflammatory effects through free-radical scavenging and membrane disruption. Preclinical data demonstrate that aqueous extracts at 20–80 mg/mL significantly reduce H₂O₂-induced lipid peroxidation in HepG2 cells, and essential oil fractions achieve DPPH radical scavenging with an IC₅₀ of 3.9 μg/mL, though human clinical trials confirming respiratory efficacy remain absent.

Origin & History

Ocimum gratissimum, commonly called African basil or scent leaf, is native to tropical Africa, India, and South America, thriving in warm, humid climates with well-drained soils at low to mid elevations. In Sudan and across the Sahel, it is cultivated around homesteads and in kitchen gardens, where it is known regionally as Al-ruwag and harvested primarily for its aromatic leaves and essential oil. The plant grows as a perennial woody shrub reaching up to 1.5 meters, producing dense clusters of small white or pale-violet flowers, and is propagated easily from seed or stem cuttings across sub-Saharan Africa.

Historical & Cultural Context

Ocimum gratissimum has been integrated into the medicinal, culinary, and ritual practices of West African, East African, and South Asian communities for centuries, with its strong aromatic profile making it a distinguishing feature of traditional healing landscapes from Nigeria to Sudan to India. In the Sudanese Arabic tradition, the plant is known as Al-ruwag and occupies a specific role as a respiratory remedy, with healers and households preparing hot leaf decoctions and steam inhalations to manage coughs, chest tightness, and upper respiratory infections, a practice embedded in broader African ethnomedical frameworks that prioritize aromatic plants for pulmonary complaints. Across West Africa, particularly in Nigeria, Côte d'Ivoire, and Benin, the plant — locally called 'efirin' in Yoruba — is used simultaneously as a cooking herb in soups and as a medicine for fever, diarrhea, skin infections, and diabetes, reflecting its polyvalent cultural status. Ethnobotanical surveys conducted in the 20th and 21st centuries have systematically documented these oral traditions, providing the scholarly framework within which modern phytochemical investigations of the herb have been anchored.

Health Benefits

- **Antioxidant Protection**: Rosmarinic acid, vicenin-2, and quercetin scavenge reactive oxygen species and reduce thiobarbituric acid reactive substances (TBARS) in oxidatively stressed hepatic cells, with measurable protection observed at extract concentrations of 20–80 mg/mL in vitro.
- **Respiratory Support (Traditional)**: In Sudanese Arabic ethnomedicine, steam inhalation of boiled Al-ruwag leaves and leaf infusions are employed to relieve cough, bronchial congestion, and sinusitis, effects attributed to the volatile 1,8-cineole and eugenol content, which are known bronchodilatory and mucolytic agents in related species.
- **Antimicrobial Activity**: Eugenol and thymol, the dominant essential oil constituents, disrupt microbial cell membranes by increasing permeability and dissipating proton motive force, conferring broad-spectrum antibacterial and antifungal activity documented in multiple in vitro disk-diffusion studies.
- **Hepatoprotective Effects**: Ethanolic and aqueous extracts at 0–40 mg/kg in carbon tetrachloride (CCl₄)-induced rat liver injury models reduced hepatic steatosis, collagen deposition, and fibrosis while upregulating catalase activity, suggesting protection against oxidative hepatotoxicity.
- **Anti-inflammatory Action**: Flavonoids including luteolin and apigenin, alongside phenolic acids such as caffeic and chlorogenic acid, inhibit pro-inflammatory mediator cascades, likely through suppression of cyclooxygenase and lipoxygenase pathways, though specific NF-κB or cytokine-level quantification in O. gratissimum studies remains limited.
- **Antidiabetic Potential**: Traditional use for blood sugar management is supported by preliminary in vivo evidence suggesting leaf extracts may modulate glucose metabolism, possibly through alpha-glucosidase inhibition by flavonoid glycosides such as rutin and vitexin, though mechanistic clarity is lacking.
- **Antihypertensive Properties**: Ethnopharmacological surveys across West and East Africa record use of leaf decoctions for hypertension, with terpenoids and flavonoids theorized to promote vasodilation; formal clinical evidence is absent, and this application awaits controlled investigation.

How It Works

The antioxidant activity of Al-ruwag is driven primarily by phenolic acids (rosmarinic acid, caffeic acid, chlorogenic acid) and flavonoids (luteolin, quercetin, vicenin-2), which donate hydrogen atoms to neutralize free radicals and chelate transition metals, thereby reducing lipid peroxidation and upregulating endogenous antioxidant enzymes including catalase and superoxide dismutase in hepatic tissue. Eugenol and thymol, the dominant essential oil constituents, disrupt prokaryotic and fungal membrane integrity by intercalating into the phospholipid bilayer, increasing ion permeability, and collapsing the proton gradient necessary for ATP synthesis, accounting for the herb's documented antimicrobial properties. Anti-inflammatory effects are attributed to the capacity of luteolin, apigenin, and rosmarinic acid to suppress arachidonic acid cascade enzymes (cyclooxygenase-2 and 5-lipoxygenase), reducing prostaglandin and leukotriene synthesis, though direct binding affinity data for O. gratissimum isolates are not yet published. The bronchodilatory and expectorant actions traditionally ascribed to respiratory use are most plausibly mediated by 1,8-cineole, which at pharmacologically relevant concentrations inhibits airway smooth muscle contraction and stimulates mucociliary clearance, consistent with well-characterized mechanisms of this monoterpene in clinical studies of other eucalyptol-rich herbs.

Scientific Research

The evidence base for Al-ruwag (Ocimum gratissimum) consists entirely of preclinical research — in vitro cell culture experiments and in vivo rodent models — with no published randomized controlled trials or other human clinical studies identified as of the current literature search. Key in vitro findings include statistically significant reductions in H₂O₂-induced TBARS in HepG2 hepatocyte cultures at extract concentrations of 20–80 mg/mL, and essential oil antioxidant IC₅₀ values of 3.9 μg/mL (DPPH assay) and 3.13 mg/mL (ABTS assay), indicating potent radical-scavenging capacity. Rodent hepatotoxicity models using CCl₄ administration demonstrated dose-dependent hepatoprotection at 0–40 mg/kg oral extract doses, with histological reductions in steatosis and fibrosis and measurable increases in hepatic catalase activity, though interspecies translation to humans is uncertain. The body of evidence is categorized as preliminary, and the traditional respiratory indication specifically lacks any controlled mechanistic or clinical investigation; phytochemical characterization studies are the most robust contribution of the current literature.

Clinical Summary

No human clinical trials have evaluated Al-ruwag (Ocimum gratissimum) for any indication, including its primary traditional use as a Sudanese respiratory remedy; all pharmacological outcome data derive from cell-based or animal experiments. Preclinical hepatoprotective studies in CCl₄-intoxicated rodents recorded histopathological improvements and catalase upregulation at 0–40 mg/kg doses, but effect sizes and p-values were not universally reported across publications, limiting meta-analytic synthesis. Antioxidant assay results (DPPH IC₅₀ = 3.9 μg/mL) are pharmacologically impressive but measured under in vitro conditions that do not account for absorption, distribution, metabolism, or excretion in living systems. Confidence in therapeutic claims for this ingredient remains low by evidence-based medicine standards; clinical translation of promising preclinical signals requires well-designed Phase I safety trials followed by controlled efficacy studies before therapeutic recommendations can be issued.

Nutritional Profile

The leaves of Ocimum gratissimum provide modest macronutrients typical of aromatic leafy herbs, with primary nutritional significance arising from their dense phytochemical content rather than caloric contribution. Key bioactive phytochemicals include phenolic acids — rosmarinic acid, caffeic acid, chlorogenic acid, sinapic acid, ellagic acid, and L-chicoric acid — alongside flavonoids such as luteolin, apigenin, quercetin, rutin, kaempferol, vicenin-2, vitexin, isovitexin, and epicatechin, with total phenolic content varying substantially by geographic origin and extraction solvent. The essential oil fraction contributes eugenol (up to 76.01% in some chemotypes), thymol (up to 29.5%), γ-terpinene (up to 20.5%), p-cymene (up to 12.9%), 1,8-cineole (0.30–23.04%), carvacrol (0.20–8.40%), β-caryophyllene, α-pinene, β-pinene, limonene, and sesquiterpenes including α-trans-bergamotene and (Z,E)-α-farnesene. Micronutrients include ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E), contributing to the plant's antioxidant capacity; tannins, alkaloids, terpenoids including oleanolic acid, and glycosides round out the phytochemical spectrum. Bioavailability of polyphenols is subject to gut microbiota metabolism, food matrix interactions, and individual variation; eugenol undergoes hepatic glucuronidation and sulfation, producing water-soluble metabolites with variable systemic distribution.

Preparation & Dosage

- **Fresh Leaf Infusion (Traditional Tea)**: A small handful (approximately 5–10 g) of fresh leaves steeped in 250 mL of boiling water for 10–15 minutes; consumed 1–2 times daily in Sudanese ethnomedicine for cough and respiratory congestion.
- **Steam Inhalation**: Fresh or dried leaves added to a bowl of boiling water; vapors inhaled under a towel for 5–10 minutes to relieve nasal and bronchial congestion, leveraging volatile eugenol and 1,8-cineole content.
- **Aqueous Extract (Research Grade)**: Preclinical hepatoprotective studies used 0–40 mg/kg body weight in rodents; no equivalent human dose established via allometric scaling or clinical trial.
- **Ethanolic Extract (Laboratory)**: Effective in vitro concentrations of 20–80 mg/mL for antioxidant and cytoprotective assays; not directly applicable to oral supplementation without bioavailability data.
- **Essential Oil (Topical/Aromatic)**: Steam-distilled EO used at 0.1% concentration in antioxidant in vitro models; eugenol-dominant chemotypes (up to 76% eugenol) used topically or aromatically in traditional practice, with caution warranted due to eugenol's known dermal sensitization potential.
- **Dried Leaf Powder**: Used in soups and condiment preparations in West Africa; no standardized supplemental dose exists, and commercial encapsulated forms are not widely available or studied.
- **Standardization Note**: No commercial standardization to specific marker compounds (e.g., eugenol percentage or rosmarinic acid content) has been established; chemotype variation significantly affects potency.

Synergy & Pairings

Eugenol-rich preparations of Al-ruwag may synergize with other phenolic-dense herbs such as ginger (Zingiber officinale) or black pepper (Piper nigrum) in respiratory formulations, as piperine enhances polyphenol bioavailability through inhibition of intestinal glucuronidation and P-glycoprotein efflux, potentially amplifying the systemic delivery of rosmarinic acid and flavonoids. In traditional Sudanese and West African polyherbal preparations, Al-ruwag is frequently combined with other aromatic plants rich in monoterpenes (e.g., 1,8-cineole-containing species), creating complementary mucolytic and antimicrobial profiles that may produce additive or synergistic antimicrobial effects as demonstrated for eugenol-thymol combinations in in vitro checkerboard assays. Pairing with honey is documented in several African ethnomedicinal traditions, which may enhance mucosal coating, provide additional antimicrobial activity via hydrogen peroxide and defensins, and improve palatability of the bitter leaf decoction.

Safety & Interactions

Formal human toxicology data for Ocimum gratissimum are absent from the published literature, and no maximum safe dose, no-observed-adverse-effect level (NOAEL), or tolerable upper intake level has been established for any preparation form; preclinical rodent studies at 0–40 mg/kg showed no overt organ toxicity, but these findings cannot be directly extrapolated to human safety profiles. Eugenol, a dominant essential oil constituent (up to 76%), is a documented dermal and mucosal sensitizer at high concentrations and a known inhibitor of platelet aggregation, raising theoretical concerns about potentiation of anticoagulant and antiplatelet medications (e.g., warfarin, aspirin, clopidogrel) if the essential oil is ingested in pharmacological quantities. Thymol and carvacrol, present in some chemotypes, are metabolized via hepatic CYP450 enzymes and may theoretically interact with drugs sharing those metabolic pathways, though no pharmacokinetic drug interaction studies in humans have been conducted for this species specifically. Pregnancy and lactation safety is unestablished; given the herb's traditional classification as an emmenagogue in some regional practices and the uterine stimulant potential of eugenol reported in related Ocimum species, avoidance during pregnancy is prudent until controlled safety data are available.